SR604 Advances to Phase 3 in Hemophilia A and B

Company Shanghai RAAS Event Type Clinical Trial Progression (Source Gap Catch-Up) Modality Monoclonal Antibody Asset SR604 Target Activated Protein C Disease Area Hemophilia A and B Summary Shanghai RAAS disclosed on 17 September that SR604 entered a single arm multicenter Phase 3 study for prophylaxis…